American journal of cardiovascular drugs : drugs, devices, and other interventions

The most recent articles from: Am J Cardiovasc Drugs February 2018

Am J Cardiovasc Drugs · Feb 2018

Randomized Controlled Trial Multicenter Study

Targeting the Prostacyclin Pathway with Selexipag in Patients with Pulmonary Arterial Hypertension Receiving Double Combination Therapy: Insights from the Randomized Controlled GRIPHON Study.

In pulmonary arterial hypertension (PAH), combination therapy is an important treatment strategy. Although randomized controlled trial data are available to support the combination of two therapies, data regarding triple combination therapy are few. ⋯ NCT01106014.

expand abstract… mark as read…

Want more great medical articles?

Keep up to date with a free trial of metajournal, personalized for your practice.
1,706,642 articles already indexed!